Looks like you clickedhttps://www.urotoday.com/conference-highlights/esmo-2023/esmo-2023-prostate-cancer/147482-esmo-2023-enzalutamide-monotherapy-for-the-treatment-of-prostate-cancer-with-high-risk-biochemical-recurrence-embark-secondary-endpoints.html
If you do not want to visit that page, you can close this browser tab.
